HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Li Selected Research

Antisense RNA (Anti-Sense RNA)

12/2020Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
1/2020Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis.
1/2020Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis.
1/2019LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
1/2015Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.
10/2014Long noncoding RNA HOTAIR involvement in cancer.
3/2010Knockdown of TSPAN1 by RNA silencing and antisense technique inhibits proliferation and infiltration of human skin squamous carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Li Research Topics

Disease

841Neoplasms (Cancer)
12/2022 - 02/2002
233Infections
12/2022 - 03/2003
172Inflammation (Inflammations)
11/2022 - 05/2003
156Neoplasm Metastasis (Metastasis)
02/2022 - 08/2003
137Breast Neoplasms (Breast Cancer)
11/2022 - 07/2005
100Carcinogenesis
11/2022 - 08/2005
100Hepatocellular Carcinoma (Hepatoma)
08/2022 - 11/2002
84Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 08/2005
73Lung Neoplasms (Lung Cancer)
06/2022 - 06/2004
65Fibrosis (Cirrhosis)
07/2022 - 02/2005
55Pain (Aches)
01/2022 - 09/2009
52Carcinoma (Carcinomatosis)
07/2022 - 02/2002
51Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 12/2010
47Stomach Neoplasms (Stomach Cancer)
05/2022 - 11/2009
45Hypoxia (Hypoxemia)
11/2022 - 07/2012
45COVID-19
08/2022 - 01/2020
43Adenocarcinoma of Lung
03/2022 - 12/2009
42Wounds and Injuries (Trauma)
06/2022 - 06/2002
39Alzheimer Disease (Alzheimer's Disease)
07/2022 - 11/2008
39Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 11/2005
39Hypertension (High Blood Pressure)
02/2022 - 12/2004
37Type 2 Diabetes Mellitus (MODY)
07/2022 - 12/2007
33Ischemia
10/2022 - 08/2007
33Body Weight (Weight, Body)
09/2022 - 03/2004
33Prostatic Neoplasms (Prostate Cancer)
06/2022 - 02/2003
33Reperfusion Injury
01/2022 - 08/2007
32Myocardial Infarction
07/2022 - 04/2007
31Sepsis (Septicemia)
01/2022 - 07/2006
30Colonic Neoplasms (Colon Cancer)
04/2022 - 07/2003
30Cognitive Dysfunction
01/2022 - 04/2008
29Pneumonia (Pneumonitis)
01/2022 - 10/2012
28Insulin Resistance
01/2022 - 12/2004
27Necrosis
02/2022 - 02/2006
27Melanoma (Melanoma, Malignant)
01/2022 - 11/2005
27Atherosclerosis
01/2022 - 11/2004
27Thrombosis (Thrombus)
01/2021 - 07/2008
26Leukemia
04/2022 - 01/2001
26Bacterial Infections (Bacterial Infection)
02/2022 - 08/2004
26Obesity
01/2022 - 10/2007
25Osteosarcoma (Osteogenic Sarcoma)
11/2021 - 04/2007
25Lymphatic Metastasis
04/2021 - 02/2003
24Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 10/2007
24Glioma (Gliomas)
03/2022 - 07/2003
24Disease Progression
01/2022 - 05/2010
24Heart Failure
01/2022 - 09/2003
23Hemorrhage
06/2022 - 01/2009
23Nasopharyngeal Carcinoma
02/2022 - 08/2004
23Rheumatoid Arthritis
01/2022 - 01/2007
23Osteoarthritis
01/2022 - 10/2012
22Chronic Hepatitis B
03/2022 - 07/2006
22Hepatitis B
01/2022 - 06/2004

Drug/Important Bio-Agent (IBA)

314Proteins (Proteins, Gene)FDA Link
08/2022 - 02/2003
183Biomarkers (Surrogate Marker)IBA
12/2022 - 05/2007
163Pharmaceutical PreparationsIBA
10/2022 - 07/2005
120CytokinesIBA
05/2022 - 02/2006
101Biological ProductsIBA
12/2022 - 06/2002
87RNA (Ribonucleic Acid)IBA
12/2022 - 07/2005
86MicroRNAs (MicroRNA)IBA
02/2022 - 12/2009
83Messenger RNA (mRNA)IBA
05/2022 - 07/2002
67Long Noncoding RNAIBA
07/2022 - 01/2013
65Glucose (Dextrose)FDA LinkGeneric
06/2022 - 07/2003
60VaccinesIBA
10/2022 - 09/2002
55DNA (Deoxyribonucleic Acid)IBA
12/2022 - 12/2004
54Therapeutic UsesIBA
11/2022 - 04/2005
51LipidsIBA
11/2022 - 05/2002
50Small Interfering RNA (siRNA)IBA
12/2022 - 11/2004
48EnzymesIBA
02/2022 - 01/2007
42Cisplatin (Platino)FDA LinkGeneric
07/2022 - 11/2004
41CateninsIBA
07/2022 - 08/2011
40Interleukin-6 (Interleukin 6)IBA
03/2022 - 02/2005
39AntigensIBA
02/2022 - 06/2002
37Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 11/2003
37Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2003
36Peptides (Polypeptides)IBA
10/2022 - 09/2002
34LigandsIBA
01/2022 - 04/2002
32LipopolysaccharidesIBA
01/2022 - 11/2003
30CollagenIBA
03/2022 - 06/2002
29Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 05/2003
28C-Reactive ProteinIBA
02/2022 - 12/2011
26AntioxidantsIBA
06/2022 - 01/2003
26Cadherins (E-Cadherin)IBA
05/2022 - 02/2003
26Insulin (Novolin)FDA Link
01/2022 - 12/2004
25Folic Acid (Vitamin M)FDA LinkGeneric
07/2022 - 08/2005
25Hormones (Hormone)IBA
06/2022 - 02/2003
25CholesterolIBA
05/2022 - 06/2006
25Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 01/2001
24ErbB Receptors (EGF Receptor)IBA
11/2021 - 08/2004
23Interleukin-10 (Interleukin 10)IBA
08/2022 - 05/2009
23Oxygen (Dioxygen)IBA
06/2022 - 08/2010
23salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2010
22Antiviral Agents (Antivirals)IBA
12/2022 - 02/2006
22Phosphotransferases (Kinase)IBA
01/2022 - 10/2006
21Circular RNAIBA
11/2022 - 01/2018

Therapy/Procedure

374Therapeutics
07/2022 - 11/2004
125Drug Therapy (Chemotherapy)
07/2022 - 11/2005
46Immunotherapy
12/2022 - 04/2007
31Radiotherapy
10/2022 - 08/2003
31Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 09/2008
31Stents
02/2022 - 04/2009
22Transplantation
09/2022 - 01/2005